Valerie Ann Bell, FNP-BC,NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 438 Ash St, Bethany, PA 18431 Phone: 570-253-8048 |
News Archive
Joachim Messing, among the world's top experts in molecular genetics, became famous for developing a genetic engineering technique used in laboratories to create plants that have produced disease-resistant crops considered vital to feeding the world's population.
NPR began a series called "Is That So?": "As the debate about the health overhaul bill goes on (and on and on) you might find that sometimes what one Senator says seems to be the exact opposite of the next." In the first installment, NPR's Julie Rovner examined Sen. Christopher Dodd's statement: "On the day this bill is enacted, health insurance becomes a buyer's market, not a seller's market. And that's as American as apple pie," and found that "it may be so eventually, but definitely not on the day the bill is enacted."
Environmental Tectonics Corporation today announced that its BioMedical Division will be exhibiting their new BARA-MED Select monoplace hyperbaric chamber. This new chamber, which is an addition to ETC's monoplace line, includes an undercarriage gurney storage for optimized space usage and features a fourth-generation, automated computerized operating system for control and recordkeeping, a passive pressure relief mattress, SMOOTH-RIDEā¢, and an adjustable height gurney and computerized treatment protocols.
Even before dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.
› Verified 1 days ago